Gianluca De Rubeis: A Safer Approach to Antiplatelet Timing in Endovascular Aneurysm Treatment
Gianluca De Rubeis, Interventional Neuroradiologist at San Camillo Forlanini Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Neuroradiology, adding:
”’The timing of intraprocedural antiplatelet therapy did not affect outcomes in endovascular treatment of ruptured intracranial aneurysms’ — our systematic review is now live.
Here’s the key takeaway: antiplatelet therapy — given to reduce thromboembolic complications — doesn’t need to be administered at the very start of the procedure.
It can be safely delayed until after the first coil is deployed, with no difference in outcomes.
Why does this matter?
Once the first coil is in place, the aneurysm is protected.
Giving antiplatelet therapy at that point keeps the same efficacy against clot complications — while making the overall procedure safer.
A simple but important shift in how we think about timing in the most critical moments of endovascular treatment.
Proud of this work and the incredible team behind it.”
Title: The timing of intraprocedural antiplatelet therapy did not affect outcomes in endovascular treatment of ruptured intracranial aneurysms: A systematic review
Authors: Gianluca De Rubeis, Sebastiano Fabiano, Luca Bertaccini, Alberto Vito Terrana, Riccardo Ricciuti, Luca Saba, Enrico Pampana
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 27, 2026, 12:17Navid Radfar: Moving Beyond CHA₂DS₂-VASc and De-Risking Atrial Fibrillation
-
Jun 27, 2026, 12:09Mapillar Dahn: Empowering Sickle Cell Warriors Through Awareness and Support
-
Jun 27, 2026, 12:00Ney Carter Borges: FAVOR III China Demonstrates a 37% Reduction in Myocardial Infarction with QFR Guidance
-
Jun 27, 2026, 11:52Abuzar Ghaffari: A Proud Milestone in My Professional Journey at ISBT 2026
-
Jun 27, 2026, 05:53Manuel Gutiérrez de Ravé: My Personal Takeaways from 39th International ISBT Annual Congress
-
Jun 27, 2026, 05:4710-Minute Paper-Strip Test Detects Factor VIII Inhibitors in Resource-Limited Settings – JTH
-
Jun 27, 2026, 05:23New episode – From Groundbreaking Therapies to the Ongoing Fight for Diagnosis – Global Hemophilia Report
-
Jun 27, 2026, 05:08Bethany Brown: Over 400 Ground EMS Agencies Now Carry Lifesaving Blood
-
Jun 27, 2026, 04:56Reza Shojaei: The Plasma Risk Governments Are Ignoring